This study showed that parthenolide can differently modify the redox state of KEAP1 in tumor and normal prostate cells suggesting a possible use of this compound as tumor-specific radiosensitizing agent with radioprotective properties in normal cells. Here, KEAP1 is linked to neoplasm.